Company specifications
The startup produces and markets reagents protected by international patents that significantly reduce the time and cost of genetic diagnostic tests in oncology. These reagents are used by hospitals, research centers, and diagnostic laboratories: every year, hospital facilities have to treat 15 million new patients. The size of the global reagents market is substantial (almost $2B), as is the expected growth rate (9% per year).
Target
The company is seeking a financial or industrial partner for a €1.2 million capital increase to fund growth. A venture capital fund and a regional development agency have already expressed a soft commitment to contribute €400k.
Complimentary guide to M&A Transactions
We are at your disposal.
YON Business Share
the B2B for M&A PROFESSIONALS
Write to us and we will get back to you as soon as possible !
We use technical cookies and, with your consent, also analytics and marketing cookies to personalise content and advertisements, offer social features and analyse traffic. Find out more in the Cookie Policy.
CONSENT ID:
DATE CONSENT:
Cookies related to activities strictly necessary for the operation of the site and the provision of services that do not require consent. Please refer to the full cookie policy for more details.
Analytical cookies help website owners understand how visitors interact with sites by collecting and transmitting information that is also used by third parties, including in disaggregated form, to manage statistics. Please refer to the full cookie policy for more details.
Marketing Marketing cookies are used to track visitors on websites. The intent is to display ads that are relevant and engaging to the individual user and therefore those of greatest value to publishers and advertisers third parties. They are used to deliver advertisements based on interests expressed through Internet browsing (OBA). Please refer to the full cookie policy for more details.